… is a new type of treatment for genital warts. Its antiviral activity is mediated in part by its ability
to stimulate the … It is formulated as a 5% cream for application to genital warts by the patient. …

… of a systematic review of the epidemiology of AGWs in the literature, this study reviewed the
… AGWs are also often referred to as genital warts, condylomata acuminata or genital verruca, …

… Other disadvantages of cryotherapy are that multiple outpatient visits are required and the
pain associated with its application can limit its repeated use in certain subjects. However, the …

… The safety of imiquimod during pregnancy is not established and thus its use is contraindicated
in pregnancy. Animal studies do not show that imquimod to be teratogenic or fetotoxic, …

… External genital warts (EGWs) are visible warts that occur in the perigenital and perianal
regions. They are due primarily to non-oncogenic human papillomavirus (HPV) types, usually …

… A recent cost-effectiveness analysis 10 found that treatment for simple genital warts costs
approximately $200 to $300 for one course of podofilox, cryotherapy, electrodesiccation, …

… treatments are available for genital warts caused by human papillomavirus (HPV), none are
… level of cure rates against warts. With all current treatments, recurrent warts are common. …

… rate of genital warts has been generally provided. The aim of this review is to assess, from
randomized control trials (RCTs), the efficacy and safety of interferon in curing genital warts. …

… This universal inferiority of podophyllin calls into question its use in clinical practice, and
some guidelines recommend it should not be used19. Systemic interferons and topical 5-Ŋ …

… This review presents the new approaches to the treatment and management of genital
warts, while … ) because readers might have heard about them and wondered about their use. …